US 7662779
Triazolyl macrocyclic hepatitis C serine protease inhibitors
granted A61KA61K31/4192A61K31/427
Quick answer
US patent 7662779 (Triazolyl macrocyclic hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/4192, A61K31/427, A61K31/4439, A61K31/4709